Home > Journals > Journal of Neurosurgical Sciences > Past Issues > Journal of Neurosurgical Sciences 2017 October;61(5) > Journal of Neurosurgical Sciences 2017 October;61(5):495-503

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

JOURNAL OF NEUROSURGICAL SCIENCES

A Journal on Neurosurgery


Indexed/Abstracted in: e-psyche, EMBASE, PubMed/MEDLINE, Neuroscience Citation Index, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,522


eTOC

 

ORIGINAL ARTICLE  


Journal of Neurosurgical Sciences 2017 October;61(5):495-503

DOI: 10.23736/S0390-5616.16.03263-X

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English

Neuroprotective effects of pregabalin in a rat model of intracisternal facial nerve avulsion

Shigeta MORIYA 1, Mitsuhiro HASEGAWA 1, Joji INAMASU 1 , Hirotaka KOGAME 1, Yuichi HIROSE 1, Ryo HIGASHI 2, Makoto ITO 3, Fumihiro IMAI 4

1 Department of Neurosurgery, Fujita Health University School of Medicine, Toyoake, Japan; 2 Department of Neurosurgery, Komatsu Municipal Hospital, Komatsu, Japan; 3 Department of Pediatric Otolaryngology, Jichi Children’s Medical Center Tochigi, Jichi Medical University, Shimotsuke, Japan; 4 Ichiriyama-Imai Clinic, Kariya, Japan


PDF  


BACKGROUND: Pregabalin (PGB), a drug used for treating neuropathic pain, has immune-modulating property that may have therapeutic implications. Suppression of microglial activation and improvement in functional recovery was observed in experimental spinal cord injury after PGB administration. An experimental study was conducted to evaluate whether PGB could afford neuroprotection in a rat model of intracisternal facial nerve avulsion.
METHODS: Twenty-eight male Wistar rats (250-300 g) were dichotomized into two groups: a PGB group (N.=14) and a control group (N.=14). The PGB group received a total of 4 intraperitoneal PGB injections (30 mg/kg, 15 minutes preoperatively and 4, 24, and 48 hours postoperatively), and the control group underwent intraperitoneal saline injection. Intracisternal facial nerve avulsion was created by tangential pull-out of the nerve surgically exposed at the stylomastoid foramen. In both groups, the brainstem containing the facial motor nuclei neurons was thin-sliced and stained with cresyl violet, and the number of viable neurons in the facial motor nuclei on days 14 and 28 was counted under microscope.
RESULTS: The total viable neuron count was significantly greater in the PGB group than in the Control group both on day 14 (271.4±14.9 vs. 196.2±22.2, P<0.01) and day 28 (160.2±21.6 vs. 102.6±13.4, P<0.01). Furthermore, CD11b/c immunostaining on days 3 and 8 showed that CD11b/c-positive cells, suggestive of activated microglia, were observed only in the control group.
CONCLUSIONS: Better neuronal survival by PGB administration may be beneficial and clinically relevant when surgical reconstruction of the facial nerve, such as hypoglossal-facial nerve anastomosis, is considered.


KEY WORDS: Facial nerve injuries - Microglia - Neuroprotection - Pregabalin

top of page

Publication History

Issue published online: July 17, 2017
Article first published online: March 17, 2015
Manuscript accepted: March 13, 2015
Manuscript received: March 10, 2015

Cite this article as

Moriya S, Hasegawa M, Inamasu J, Kogame H, Hirose Y, Higashi R, et al. Neuroprotective effects of pregabalin in a rat model of intracisternal facial nerve avulsion. J Neurosurg Sci 2017;61:495-503. DOI: 10.23736/S0390-5616.16.03263-X

Corresponding author e-mail

inamasu@fujita-hu.ac.jp